RESUMEN
Burkholderia pseudomallei is the causative agent of melioidosis, which is a Gram negative, facultative intracellular bacterium. Disease is prevalent in SE Asia and in northern Australia, as well as in other tropical and subtropical regions. Recently, there is an increasing awareness of the importance of bacterial ingestion as a potential route of infection, particularly in cases of unexplained origin of the disease. The marmoset is a New World Monkey (NWM) species that is being developed as an alternative NHP model to complement the more traditionally used Old World Monkeys (OWM). Models have been developed for the traditional routes of disease acquisition, subcutaneous and inhalational. This manuscript details the development and characterisation of an ingestion model of melioidosis. Dose-ranging study assessed the lethality of B. pseudomallei and disease progression was assessed by euthanizing animals at predetermined time points, 12, 36, 48 and 54 hours post-challenge. Challenge doses of greater than 6.2 x 106 cfu resulted in an acute, lethal, febrile disease. Following challenge the lung was the first organ, outside of the gastrointestinal tract, to become colonised. Enteritis (duodenitis, ileitis and/or jejunitis) was observed in sections of the small intestine from animals that succumbed to disease. However, the most severe pathological features were observed in the mesenteric lymph nodes from these animals. These findings are consistent with lymphatic draining as route of dissemination.
Asunto(s)
Burkholderia pseudomallei/fisiología , Sistema Linfático/microbiología , Melioidosis/patología , Animales , Burkholderia pseudomallei/patogenicidad , Callithrix , Modelos Animales de Enfermedad , Enteritis/microbiología , Femenino , Pulmón/microbiología , Ganglios Linfáticos/microbiología , Ganglios Linfáticos/patología , Masculino , Melioidosis/microbiologíaRESUMEN
The Gram-negative bacterium Burkholderia pseudomallei causes melioidosis and is a CDC category B bioterrorism agent. Toll-like receptor (TLR)-2 impairs host defense during pulmonary B.pseudomallei infection while TLR4 only has limited impact. We investigated the role of TLRs in B.pseudomallei-lipopolysaccharide (LPS) induced inflammation. Purified B.pseudomallei-LPS activated only TLR2-transfected-HEK-cells during short stimulation but both HEK-TLR2 and HEK-TLR4-cells after 24 h. In human blood, an additive effect of TLR2 on TLR4-mediated signalling induced by B.pseudomallei-LPS was observed. In contrast, murine peritoneal macrophages recognized B.pseudomallei-LPS solely through TLR4. Intranasal inoculation of B.pseudomallei-LPS showed that both TLR4-knockout(-/-) and TLR2x4-/-, but not TLR2-/- mice, displayed diminished cytokine responses and neutrophil influx compared to wild-type controls. These data suggest that B.pseudomallei-LPS signalling occurs solely through murine TLR4, while in human models TLR2 plays an additional role, highlighting important differences between specificity of human and murine models that may have important consequences for B.pseudomallei-LPS sensing by TLRs and subsequent susceptibility to melioidosis.
Asunto(s)
Burkholderia pseudomallei/patogenicidad , Interacciones Huésped-Patógeno , Lipopolisacáridos/metabolismo , Receptor Toll-Like 2/metabolismo , Receptor Toll-Like 4/metabolismo , Animales , Burkholderia pseudomallei/metabolismo , Células HEK293/metabolismo , Células HEK293/microbiología , Humanos , Lipopolisacáridos/aislamiento & purificación , Lipopolisacáridos/toxicidad , Melioidosis/metabolismo , Melioidosis/microbiología , Ratones Endogámicos C57BL , Ratones Mutantes , Neumonía Bacteriana/inducido químicamente , Neumonía Bacteriana/metabolismo , Neumonía Bacteriana/microbiología , Transducción de Señal , Receptor Toll-Like 2/genética , Receptor Toll-Like 4/genética , Factores de Virulencia/metabolismoRESUMEN
The marmoset model of melioidosis was used to explore whether there was any difference in the disease presentation and/or the lesion formation following inhalational challenge with one of four strains of Burkholderia pseudomallei (K96243, 1026b, HBPUB10303a and HBPUB10134a). Marmosets were challenged with a range of bacterial doses and bacterial load, histological and physiological features were determined temporally following lethal disease. Melioidosis presented as an acute, febrile disease with bacteraemia, bacterial dissemination, necrotizing hepatitis, splenitis and pneumonia which was independent of the challenge strain. Generally, there were no major differences in the manifestation of melioidosis following challenge by the different strains of B. pseudomallei; however, there were some differences in the time to death and the severity of the pathological features. The pathological features observed in the liver and spleen of animals challenged with B. pseudomallei strain 1026b were statistically less severe (P < 0.05) and less frequent. However, more severe foci of disease were evident in the lungs of animals challenged with strain 1026b. In all cases, the lesions developed from small areas of bacteria-infected macrophages surrounded by non-infected neutrophils into large lesions with both immune cell types infected. The marmoset model was a useful tool enabling the distinction of subtle difference in the pathological response to B. pseudomallei.
Asunto(s)
Burkholderia pseudomallei/patogenicidad , Exposición por Inhalación , Hígado/patología , Pulmón/patología , Melioidosis/patología , Bazo/patología , Aerosoles , Animales , Carga Bacteriana , Burkholderia pseudomallei/clasificación , Callithrix , Modelos Animales de Enfermedad , Progresión de la Enfermedad , Femenino , Interacciones Huésped-Patógeno , Hígado/microbiología , Pulmón/microbiología , Macrófagos/microbiología , Macrófagos/patología , Masculino , Melioidosis/microbiología , Neutrófilos/patología , Índice de Severidad de la Enfermedad , Bazo/microbiología , Factores de TiempoRESUMEN
Glanders and melioidosis are caused by two distinct Burkholderia species and have generally been considered to have similar disease progression. While both of these pathogens are HHS/CDC Tier 1 agents, natural infection with both these pathogens is primarily through skin inoculation. The common marmoset (Callithrix jacchus) was used to compare disease following experimental subcutaneous challenge. Acute, lethal disease was observed in marmosets following challenge with between 26 and 1.2 × 10(8) cfu Burkholderia pseudomallei within 22-85 h. The reproducibility and progression of the disease were assessed following a challenge of 1 × 10(2) cfu of B. pseudomallei. Melioidosis was characterised by high levels of bacteraemia, focal microgranuloma progressing to non-necrotic multifocal solid lesions in the livers and spleens and multi-organ failure. Lethal disease was observed in 93% of animals challenged with Burkholderia mallei, occurring between 5 and 10.6 days. Following challenge with 1 × 10(2) cfu of B. mallei, glanders was characterised with lymphatic spread of the bacteria and non-necrotic, multifocal solid lesions progressing to a multifocal lesion with severe necrosis and pneumonia. The experimental results confirmed that the disease pathology and presentation is strikingly different between the two pathogens. The marmoset provides a model of the human syndrome for both diseases facilitating the development of medical countermeasures.
Asunto(s)
Burkholderia mallei , Burkholderia pseudomallei , Muermo/microbiología , Muermo/patología , Melioidosis/microbiología , Melioidosis/patología , Animales , Antígenos Bacterianos , Carga Bacteriana , Callithrix , Modelos Animales de Enfermedad , Femenino , Muermo/mortalidad , Inyecciones Subcutáneas , Masculino , Melioidosis/mortalidad , Índice de Severidad de la EnfermedadRESUMEN
Melioidosis is a severe infectious disease caused by Burkholderia pseudomallei. It is refractory to antibiotic treatment and there is currently no licensed vaccine. In this report we detail the construction and protective efficacy of a polysaccharide-protein conjugate composed of B. pseudomallei lipopolysaccharide and the Hc fragment of tetanus toxin. Immunisation of mice with the lipopolysaccharide-conjugate led to significantly reduced bacterial burdens in the spleen 48 hours after challenge and afforded significant protection against a lethal challenge with B. pseudomallei. The conjugate generated significantly higher levels of antigen-specific IgG1 and IgG2a than in lipopolysaccharide-immunised mice. Immunisation with the conjugate also demonstrated a bias towards Th1 type responses, evidenced by high levels of IgG2a. In contrast, immunisation with unconjugated lipopolysaccharide evoked almost no IgG2a demonstrating a bias towards Th2 type responses. This study demonstrates the effectiveness of this approach in the development of an efficacious and protective vaccine against melioidosis.
Asunto(s)
Anticuerpos Antibacterianos/biosíntesis , Vacunas Bacterianas/inmunología , Burkholderia pseudomallei/inmunología , Inmunoconjugados/administración & dosificación , Lipopolisacáridos/inmunología , Melioidosis/prevención & control , Fragmentos de Péptidos/inmunología , Toxina Tetánica/inmunología , Animales , Vacunas Bacterianas/administración & dosificación , Vacunas Bacterianas/química , Femenino , Inmunidad Humoral/efectos de los fármacos , Inmunización , Inmunoconjugados/química , Inmunoconjugados/inmunología , Inmunoglobulina G/biosíntesis , Lipopolisacáridos/química , Melioidosis/inmunología , Melioidosis/microbiología , Melioidosis/mortalidad , Ratones , Ratones Endogámicos BALB C , Fragmentos de Péptidos/química , Proteínas Recombinantes/química , Proteínas Recombinantes/inmunología , Análisis de Supervivencia , Toxina Tetánica/química , Balance Th1 - Th2 , Vacunas ConjugadasRESUMEN
The structure of BPSL1549, a protein of unknown function from Burkholderia pseudomallei, reveals a similarity to Escherichia coli cytotoxic necrotizing factor 1. We found that BPSL1549 acted as a potent cytotoxin against eukaryotic cells and was lethal when administered to mice. Expression levels of bpsl1549 correlate with conditions expected to promote or suppress pathogenicity. BPSL1549 promotes deamidation of glutamine-339 of the translation initiation factor eIF4A, abolishing its helicase activity and inhibiting translation. We propose to name BPSL1549 Burkholderia lethal factor 1.
Asunto(s)
Proteínas Bacterianas/química , Proteínas Bacterianas/toxicidad , Toxinas Bacterianas/química , Toxinas Bacterianas/toxicidad , Burkholderia pseudomallei/química , Burkholderia pseudomallei/patogenicidad , Factor 4A Eucariótico de Iniciación/antagonistas & inhibidores , Secuencias de Aminoácidos , Animales , Proteínas Bacterianas/genética , Proteínas Bacterianas/metabolismo , Toxinas Bacterianas/genética , Toxinas Bacterianas/metabolismo , Dominio Catalítico , Línea Celular , Cristalografía por Rayos X , Citotoxinas/química , Citotoxinas/genética , Citotoxinas/metabolismo , Citotoxinas/toxicidad , Proteínas de Escherichia coli/química , Factor 4A Eucariótico de Iniciación/metabolismo , Glutamina/metabolismo , Humanos , Ratones , Ratones Endogámicos BALB C , Modelos Moleculares , Proteínas Mutantes/toxicidad , Iniciación de la Cadena Peptídica Traduccional/efectos de los fármacos , Unión Proteica , Conformación Proteica , Estructura Secundaria de Proteína , Estructura Terciaria de ProteínaRESUMEN
The Burkholderia pseudomallei K96243 genome encodes six type VI secretion systems (T6SSs), but little is known about the role of these systems in the biology of B. pseudomallei. In this study, we purified recombinant Hcp proteins from each T6SS and tested them as vaccine candidates in the BALB/c mouse model of melioidosis. Recombinant Hcp2 protected 80% of mice against a lethal challenge with K96243, while recombinant Hcp1, Hcp3, and Hcp6 protected 50% of mice against challenge. Hcp6 was the only Hcp constitutively produced by B. pseudomallei in vitro; however, it was not exported to the extracellular milieu. Hcp1, on the other hand, was produced and exported in vitro when the VirAG two-component regulatory system was overexpressed in trans. We also constructed six hcp deletion mutants (Δhcp1 through Δhcp6) and tested them for virulence in the Syrian hamster model of infection. The 50% lethal doses (LD(50)s) for the Δhcp2 through Δhcp6 mutants were indistinguishable from K96243 (<10 bacteria), but the LD(50) for the Δhcp1 mutant was >10(3) bacteria. The hcp1 deletion mutant also exhibited a growth defect in RAW 264.7 macrophages and was unable to form multinucleated giant cells in this cell line. Unlike K96243, the Δhcp1 mutant was only weakly cytotoxic to RAW 264.7 macrophages 18 h after infection. The results suggest that the cluster 1 T6SS is essential for virulence and plays an important role in the intracellular lifestyle of B. pseudomallei.
Asunto(s)
Perfilación de la Expresión Génica , Melioidosis/microbiología , Factores de Virulencia/metabolismo , Secuencia de Aminoácidos , Animales , Proteínas Bacterianas/genética , Proteínas Bacterianas/metabolismo , Burkholderia pseudomallei/genética , Burkholderia pseudomallei/metabolismo , Cricetinae , Modelos Animales de Enfermedad , Electroforesis en Gel de Poliacrilamida , Femenino , Técnica del Anticuerpo Fluorescente , Expresión Génica , Genes Bacterianos , Humanos , Immunoblotting , Hígado/microbiología , Hígado/patología , Macrófagos/microbiología , Macrófagos/patología , Melioidosis/genética , Melioidosis/metabolismo , Mesocricetus , Ratones , Ratones Endogámicos BALB C , Datos de Secuencia Molecular , Virulencia/genética , Factores de Virulencia/genéticaRESUMEN
Burkholderia thailandensis is a less virulent close relative of Burkholderia pseudomallei, a CDC category B biothreat agent. We have previously shown that lipopolysaccharide (LPS) extracted from B. pseudomallei can provide protection against a lethal challenge of B. pseudomallei in a mouse model of melioidosis. Sugar analysis on LPS from B. thailandensis strain E264 confirmed that this polysaccharide has a similar structure to LPS from B. pseudomallei. Mice were immunised with LPS from B. thailandensis or B. pseudomallei and challenged with a lethal dose of B. pseudomallei strain K96243. Similar protection levels were observed when either LPS was used as the immunogen. This data suggests that B. thailandensis LPS has the potential to be used as part of a subunit based vaccine against pathogenic B. pseudomallei.